Guggenheim Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.5M	Buy	2,869 +708	+33%	+$338K	0.01%	814
2025 Q4	$1.26M	Buy	2,161 +536	+33%	+$274K	0.01%	829
2025 Q3	$745K	Sell	1,625 -413	-20%	-$154K	0.01%	1026
2025 Q2	$617K	Sell	2,038 -164	-7%	-$48.9K	0.01%	1076
2025 Q1	$729K	Sell	2,202 -466	-17%	-$153K	0.01%	1025
2024 Q4	$823K	Sell	2,668 -978	-27%	-$275K	0.01%	1002
2024 Q3	$774K	Buy	3,646 +311	+9%	+$79.6K	0.01%	1219
2024 Q2	$934K	Buy	3,335 +365	+12%	+$86.9K	0.01%	1156
2024 Q1	$793K	Sell	2,970 -451	-13%	-$106K	0.01%	1289
2023 Q4	$792K	Buy	3,421 +284	+9%	+$49.7K	0.01%	1266
2023 Q3	$458K	Buy	3,137 +431	+16%	+$81.1K	﹤0.01%	1468
2023 Q2	$625K	Sell	2,706 -431	-14%	-$117K	﹤0.01%	1360
2023 Q1	$760K	Buy	+3,137	New	+$855K	0.01%	1305
2019 Q4	–	Sell	-16,064	Closed	-$1.39M	–	2119
2019 Q3	$1.39M	Sell	16,064 -1,043	-6%	-$97.9K	0.01%	1167
2019 Q2	$1.79M	Buy	17,107 +926	+6%	+$99.2K	0.01%	1104
2019 Q1	$2.03M	Sell	16,181 -1,622	-9%	-$202K	0.02%	1065
2018 Q4	$2.01M	Buy	+17,803	New	+$2.76M	0.02%	1039
2015 Q3	–	Sell	-341	Closed	-$27K	–	3012
2015 Q2	$27K	Buy	+341	New	+$28.6K	﹤0.01%	2986